Crescita Therapeutics Inc. (CRRTF)
OTC PINK OTC PINK Primary Summary
CRRTF Chart
Crescita Therapeutics Inc. (CRRTF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Crescita Therapeutics Inc. ever had a stock split?
Crescita Therapeutics Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Serge Verreault CEO | OTC PINK Exchange | 14457Y109 CUSIP |
| CA Country | 65 Employees | - Last Dividend | 14 Feb 2018 Last Split | - IPO Date |
Overview
Crescita Therapeutics Inc., established in 2016 and based in Laval, Canada, is a dermatology company that specializes in providing both non-prescription skincare products and prescription drug products. With a presence in Canada, the United States, and other international markets, Crescita operates across three main segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. The company is known for owning proprietary platform technologies such as Multiplexed Molecular Penetration Enhancers (MMPE) and DuraPeel, which facilitate the development of topical treatments containing cannabis and hemp. Through its diverse portfolio and strategic partnerships with entities like Cantabria Labs Inc. and Taro Pharmaceuticals Inc., Crescita Therapeutics aims to advance dermatological care and meet various skin health needs.
Products and Services
Prescription Products:
- Pliaglis: A topical local anesthetic cream designed to provide dermal analgesia on intact skin in preparation for superficial dermatological procedures.
- CTX-101: A Phase III topical formulation combining a corticosteroid with MMPE technology to address plaque psoriasis.
- CTX-102: A Phase I topical formulation using MMPE technology aimed at treating an undisclosed dermatological skin condition.
- Dermatology Products in Pre-Clinical Formulation: Utilizes MMPE technology for the prescription treatment of various skin diseases.
Non-Prescription Portfolio:
- Laboratoire Dr Renaud: Offers dermocosmetic products such as facial creams, cleansers, exfoliants, masks, serums, and suncare, targeting mild acne, aging, dehydration, pigmentation, sensitivity, and rosacea.
- Pro-Derm and Alyria: Provides medical aesthetics products for non-invasive and minimally invasive procedures or skincare treatments.
- NCTF Boost 135 HA: A skin revitalization solution distributed by Crescita Therapeutics.
- Obagi Medical Products: Offers a range of skincare products focused on minimizing the appearance of premature skin aging, skin damage, acne, sun damage, and hyperpigmentation.
- ART FILLER: A line of hyaluronic acid-based dermal fillers aimed at enhancing and restoring facial volume and contours.
